Braveheart Bio, Inc. (BRVE) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29Nov 3

Key dataNov 3, 2026

Open$20.94

From 52W high−28.70%

Volume305539.00

Market cap$1.93B

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataNov 3, 2026

Open

$20.94

From 52W high

−28.70%

Volume

305539.00

Market cap

$1.93B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

50.2

MomentumView details →

1D Return

+1.66%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

+1.66%

YTD Return

—

1Y Return

—

RSI (14)

50.2

vs 50D SMA

−8.33%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$2.51

EPS Surprise

−193.31%

Beats (12Q)

0/12

Next Q EPS Est

—

Avg Surprise (4Q)

−193.31%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Next earningsDec 8, 2026 →

Latest newsMore news →

No recent news for BRVE.

Similar companies

Mesoblast LimitedMESO Revolution Medicines, Inc. WarrantRVMDW Mabpharm Limited02181.HK Vir Biotechnology, Inc.VIR Replimune Group, Inc.REPL Sarepta Therapeutics, Inc.SRPT Find similar companies →

Latest newsMore news →

No recent news for BRVE.